Evidence map›Paper›PMID 35720377›Full record

Trial reportFrontiers in immunology2022

Vitamin D Supplementation Modulates Platelet-Mediated Inflammation in Subjects With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.

Ebin Johny, Aishwarya Jala, Bishamber Nath, Md Jahangir Alam, Indra Kuladhipati, Rupam Das, Roshan M Borkar, Ramu Adela

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Inflammation, anemia, and vitamin D levels associate with infant thrombocytosis risk.Research and practice in thrombosis and haemostasis · 2026
    Article
  6. Unlocking the potential ofFrontiers in nutrition · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current Knowledge of the Impact of Vitamin D in Coronary Artery Disease.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Association Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ebin JohnyDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Aishwarya JalaDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Bishamber NathDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Md Jahangir AlamDepartment of Biotechnology, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Indra KuladhipatiDowntown Hospital, Guwahati, India.
Rupam DasDowntown Hospital, Guwahati, India.
Roshan M BorkarDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Ramu AdelaDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Guwahati, India.
National Institute of Pharmaceutical Education and Research · INAssam Down Town University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recently, our group identified increased platelet-mediated inflammation in type 2 diabetes (T2DM) patients, and it is a well-established risk factor for diabetes complications, particularly for the development of cardiovascular diseases (CVD). Furthermore, vitamin D is reported to play an important role in the modulation of platelet hyperactivity and immune function, although the effect of vitamin D on platelet-mediated inflammation is not well studied. Hence, we aimed to investigate the effect of vitamin D supplementation on platelet-mediated inflammation in T2DM patients. Methods: After screening a total of 201 subjects, our randomized, double-blind, placebo-controlled trial included 59 vitamin-D-deficient T2DM subjects, and the participants were randomly assigned to placebo ( Results: Six months of vitamin D supplementation increases the serum vitamin D3 and total 25(OH)D levels from the baseline ( Conclusion: Our study results provide evidence that vitamin D supportive therapy may help to reduce or prevent the disease progression and cardiovascular risk in T2DM patients by suppressing oxidative stress and platelet-mediated inflammation. Clinical Trial Registration: Clinical Trial Registry of India: CTRI/2019/01/016921.

Indexed as

Diabetes Mellitus, Type 2CholecalciferolDietary SupplementsHumansInflammationVitamin DVitaminsCholecalciferolVitamin DVitaminsinflammationoxidative stressplatelettype 2 diabetesvitamin D

Identifiers

PMID35720377
PMCPMC9205628
OpenAlexW4281675921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.